CorrespondenceVasospasm in Aneurysmal Subarachnoid Hemorrhage: An Evolving Knowledge
References (5)
An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage brain research
Brain Res Brain Res Rev
(2004)- et al.
Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?
World Neurosurg
(2012)
There are more references available in the full text version of this article.
Cited by (4)
Avoiding Complications in Aneurysm Ligation: Operative Tips and Tricks
2022, World NeurosurgeryCitation Excerpt :In 40%–60%, the mortality rate occurs within 30 days3 and among the surviving patients, about one third remains long-term dependent owing to brain injury.4 Although the progress in diagnostic, perioperative and intraoperative techniques,1,5-9 the overall outcome in aSAH patients remains inadequate.10 Numerous preclinical and clinical studies have investigated several neuroprotective agents, which have shown initial encouraging results but not conclusive in a clinical scenario.8,11-16
Is Aspirin a Worthy Candidate in Preventing Intracranial Aneurysm Rupture?
2020, World NeurosurgeryMicrosurgical Management of Intracranial Aneurysms After Flow Diversion Failure
2020, World NeurosurgeryPrognostic factors of delayed cerebral ischemia after subarachnoid hemorrhage including CT perfusion: a prospective cohort study
2020, Egyptian Journal of Radiology and Nuclear Medicine
Copyright © 2015 Elsevier Inc. All rights reserved.